Kardegic /00002703/


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 62.3%
Breast Cancer Female 4.4%
Coronary Artery Bypass 3.5%
Cardiac Failure 3.2%
Hypertension 2.6%
Prophylaxis 2.6%
Angioplasty 2.3%
Coronary Arterial Stent Insertion 2.3%
Diabetes Mellitus 2.3%
Type 2 Diabetes Mellitus 2.3%
Stent Placement 1.5%
Thrombosis Prophylaxis 1.5%
Atrial Fibrillation 1.2%
Coronary Artery Disease 1.2%
Depression 1.2%
Hiv Infection 1.2%
Hypercholesterolaemia 1.2%
Palpitations 1.2%
Phlebitis 1.2%
Angina Pectoris 0.9%
Renal Failure 11.5%
Renal Failure Acute 9.6%
Rectal Haemorrhage 7.7%
Urinary Retention 7.7%
Anaemia Haemolytic Autoimmune 5.8%
Ejection Fraction Decreased 5.8%
Melaena 5.8%
Thrombocytopenia 5.8%
Hyperglycaemia 3.8%
Lichenoid Keratosis 3.8%
Muscle Haemorrhage 3.8%
Quadriplegia 3.8%
Rash 3.8%
Rash Pustular 3.8%
Skin Exfoliation 3.8%
Tricuspid Valve Incompetence 3.8%
Vascular Purpura 3.8%
Aphthous Stomatitis 1.9%
Confusional State 1.9%
Cytolytic Hepatitis 1.9%
Concomitant
Drug Use For Unknown Indication 51.0%
Hypertension 6.8%
Type 2 Diabetes Mellitus 5.3%
Prophylaxis 5.1%
Product Used For Unknown Indication 3.7%
Multiple Myeloma 3.6%
Diabetes Mellitus 3.4%
Thrombosis Prophylaxis 2.4%
Plasma Cell Myeloma 2.1%
Cardiac Failure 2.0%
Myocardial Infarction 2.0%
Pain 2.0%
Mantle Cell Lymphoma 1.7%
Essential Hypertension 1.5%
Constipation 1.4%
Hypercholesterolaemia 1.4%
Acute Coronary Syndrome 1.3%
Arrhythmia 1.3%
Rheumatoid Arthritis 1.3%
Anxiety 1.0%
Renal Failure Acute 16.7%
Vomiting 10.8%
Thrombocytopenia 7.5%
Renal Failure 6.7%
Hypoglycaemia 5.0%
Pancytopenia 5.0%
Pruritus 5.0%
Weight Decreased 5.0%
Eczema 4.2%
Fall 4.2%
Malaise 4.2%
Urinary Retention 4.2%
Hyponatraemia 3.3%
Somnolence 3.3%
Atrial Fibrillation 2.5%
Breast Cancer 2.5%
Cytolytic Hepatitis 2.5%
Erythema Multiforme 2.5%
Haemorrhage Intracranial 2.5%
Hypotension 2.5%

Drug Data